HeartBeam Inc. (NASDAQ: BEAT)

We're looking forward to #CRT2025 where our CEO Rob Eno?will present?during the Digital Health and Artificial Intelligence session. Rob?will be discussing the?future?potential of HeartBeam?based on results from initial investigations that show a reduction of symptom-to-door times* for patients experiencing cardiac symptoms.?We hope to see you there! *????????: ?????????????????? ???????????? ???? ?????? ?????? ?????????????? ?????? ???????? ??????. ?????????? ?????? ?????????????????????????????? ???? ???????????? ???? ???????? ????????. #ECG #arrhythmia #cardiacmonitoring?#cardiology #digitalhealth #innovation?

Looking forward to our CEO Rob Eno's discussion with Lou Basenese about HeartBeam's groundbreaking?technology which captures the heart’s electrical signals from three distinct directions.?

HeartBeam CEO Rob Eno and CFO Timothy Cruickshank will be at the 37th Annual Roth Conference and #LSIUSA2025 the week of March 16. Contact us to schedule a one-on-one meeting with the team. Read the release for more details: https://lnkd.in/gryYEnpG #BEAT #ECG #cardiacmonitoring #arrhythmia #digitalhealth #medtech #innovation

Drumroll please...we're thrilled to announce HeartBeam has been recognized with the ?????????????? ???????????????? ???????????????????? ?????????? in Medical Device Innovation! The award recognizes companies that are making significant contributions to improving patient care, advancing medical technology and improving overall health outcomes. Our vision is to offer patients and physicians with an easy-to-use portable ECG device and transform how cardiac conditions are monitored and detected and it's an honor to be recognized for our work. ?? #innovation #cardiacmonitoring #remotemonitoring #cardiology #cardiaccare #digitalhealth #medtech

HeartBeam CEO?Rob Eno?and CFO?Timothy Cruickshank will host a call on Thursday, March 13 to discuss the company's results for Q4 2024 and the full year ended December 31, 2024. Join us to learn about regulatory and commercial updates, ongoing initiatives and anticipated milestones. Full call details can be found here: https://lnkd.in/gVjN2XNy

We're pleased to announce the successful closing of a $10 million public offering with our partner MDB Capital! The funding follows our recent milestone achievements of FDA clearance for our foundational patented technology which captures the heart’s electrical signals from three distinct directions,?and 510(k) application?to the FDA for our groundbreaking 12-lead ECG synthesis software. “These funds extend our cash runway and put us in a position to achieve additional upcoming milestones as we advance towards commercialization, all of which brings us closer to fulfilling our vision of providing unprecedented cardiac insights to individuals and physicians," commented CEO Rob Eno.? #BEAT #cardiacmonitoring #ECG?#arrhythmia #innovation #cardiology #digitalhealth

At HeartBeam, we understand that delaying care for cardiac symptoms can lead to worse health outcomes. That’s why we’re committed to transforming the way cardiac conditions are monitored and detected. Our vision is to empower patients with the ability to collect 12-lead ECG data wherever they are. Today, we proudly support National Wear Red Day to raise awareness about heart health and the importance of being able to monitor cardiac symptoms outside of a medical facility.? ? #wearred #heartmonth #hearthealth #ECG #cardiacmonitoring #epeeps #arrhythmia #innovation #cardiology #digitalhealth

We're excited to announce we've submitted our 510(k) application to the FDA for our groundbreaking 12-lead ECG synthesis software for assessment of common arrhythmias such as atrial fibrillation, atrial flutter, and ectopic beats. HeartBeam's proprietary technology?captures the heart's electrical signals from 3 distinct directions?and the software?synthesizes these signals into a 12-lead ECG using a personalized transformation matrix.?? ? The submission is an important step as we work towards fulfilling HeartBeam's vision to transform?how cardiac conditions are monitored and detected, and to empower patients by allowing them to collect 12-lead ECG data wherever they are. Read more in our release: https://lnkd.in/gfEsxFqF ? #ECG #cardiacmonitoring #epeeps #arrhythmia #innovation #cardiology #digitalhealth

We're excited for the 30th Annual #AFSymposium this weekend! Message us to schedule time with the team to learn more about the FDA-cleared HeartBeam System, which uniquely captures the heart's signals from three different directions for more timely detection and monitoring of arrhythmias. #AFSymposium2025 #ECG #cardiacmonitoring #epeeps #arrhythmia #innovation #digitalhealth

We've achieved many significant milestones this year as we work towards our vision of changing the future of cardiac care. We're so grateful to our talented team for their commitment and hard work, and to our investors and advisors for their ongoing support. The HeartBeam team wishes you and your loved ones a wonderful holiday season full of joy and cheer!